CRTD — Creatd Income Statement
0.000.00%
Last trade - 00:00
- $0.66m
- $9.16m
- $4.80m
- 13
- 52
- 52
- 33
2018 December 31st | 2019 December 31st | C2020 December 31st | 2021 December 31st | 2022 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 0.081 | 0.453 | 1.21 | 4.3 | 4.8 |
Cost of Revenue | |||||
Gross Profit | — | 0.453 | -0.282 | -1 | -1.31 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 9.2 | 7.83 | 23.1 | 37 | 34.7 |
Operating Profit | -9.12 | -7.38 | -21.9 | -32.7 | -29.9 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -12 | -8.04 | -24.2 | -37.4 | -35.7 |
Provision for Income Taxes | |||||
Net Income After Taxes | -12 | -8.04 | -24.2 | -37.4 | -35.7 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | -12 | -8.04 | -24.2 | -37.3 | -32.3 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -14.2 | -8.04 | -27.3 | -37.7 | -36.5 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -4,725 | -1,436 | -2,255 | -1,450 | -730 |